[go: up one dir, main page]

AU2001265019A1 - Compositions and methods for the treatment of immune related diseases - Google Patents

Compositions and methods for the treatment of immune related diseases

Info

Publication number
AU2001265019A1
AU2001265019A1 AU2001265019A AU6501901A AU2001265019A1 AU 2001265019 A1 AU2001265019 A1 AU 2001265019A1 AU 2001265019 A AU2001265019 A AU 2001265019A AU 6501901 A AU6501901 A AU 6501901A AU 2001265019 A1 AU2001265019 A1 AU 2001265019A1
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
related diseases
immune related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001265019A
Inventor
Dan L Eaton
Sherman Fong
Audrey Goddard
Paul J Godowski
Christopher J. Grimaldi
Austin L. Gurney
Colin K. Watanabe
William I. Wood
Zemin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/014941 external-priority patent/WO2000073348A2/en
Priority claimed from PCT/US2000/015264 external-priority patent/WO2000073452A2/en
Priority claimed from PCT/US2000/032678 external-priority patent/WO2001040466A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US2001/017092 external-priority patent/WO2001092331A2/en
Publication of AU2001265019A1 publication Critical patent/AU2001265019A1/en
Abandoned legal-status Critical Current

Links

AU2001265019A 2000-05-30 2001-05-25 Compositions and methods for the treatment of immune related diseases Abandoned AU2001265019A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
PCT/US2000/014941 WO2000073348A2 (en) 1999-06-02 2000-05-30 Methods and compositions for inhibiting neoplastic cell growth
AU55911/00 2000-05-30
PCT/US2000/015264 WO2000073452A2 (en) 1999-06-02 2000-06-02 Compositions and methods for the treatment of immune related diseases
AU54601/00 2000-06-02
AU20554/01 2000-12-01
PCT/US2000/032678 WO2001040466A2 (en) 1999-12-01 2000-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/017092 WO2001092331A2 (en) 2000-05-30 2001-05-25 Compositions and methods for the treatment of immune related diseases

Publications (1)

Publication Number Publication Date
AU2001265019A1 true AU2001265019A1 (en) 2001-12-11

Family

ID=27358988

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001265019A Abandoned AU2001265019A1 (en) 2000-05-30 2001-05-25 Compositions and methods for the treatment of immune related diseases

Country Status (1)

Country Link
AU (1) AU2001265019A1 (en)

Similar Documents

Publication Publication Date Title
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
EP1572116A4 (en) Compositions and methods for the treatment of immune related diseases
EP1576137A4 (en) Compositions and methods for the treatment of immune related diseases
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
IL145470A0 (en) Compositions for the treatment of immune diseases
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
EP1560593A4 (en) Novel composition and methods for the treatment of immune related diseases
AU2002352533A1 (en) Methods and compositions for treatment of gastric diseases
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
HUP0302718A3 (en) Methods and compositions for the treatment of diseases of the eye
EP1578373A4 (en) Novel compositions and methods for the treatment of immune related diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
WO2004024076A8 (en) Novel compositions and methods for the treatment of immune related diseases
EP1472273A4 (en) Compositions and methods for the treatment of immune related diseases
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications